share_log

Keros Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alkeon Capital Management, LLC(5.0%),Panayotis D. Sparaggis(5.0%)

Keros Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Alkeon Capital Management, LLC(5.0%),Panayotis D. Sparaggis(5.0%)

美股sec公告 ·  02/13 18:40
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息